    <SEC-DOCUMENT>0001193125-25-060364-index.html : 20250321
    <SEC-HEADER>0001193125-25-060364.hdr.sgml : 20250321
    <ACCEPTANCE-DATETIME>20250321172647
    ACCESSION NUMBER:		0001193125-25-060364
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250321
    DATE AS OF CHANGE:		20250321
    EFFECTIVENESS DATE:		20250321

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Lantheus Holdings, Inc.
    		CENTRAL INDEX KEY:			0001521036
    		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				352318913
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36569
    		FILM NUMBER:		25761655

    	BUSINESS ADDRESS:
    		STREET 1:		331 TREBLE COVE ROAD
    		CITY:			NORTH BILLERICA
    		STATE:			MA
    		ZIP:			01862
    		BUSINESS PHONE:		978 671-8001

    	MAIL ADDRESS:
    		STREET 1:		331 TREBLE COVE ROAD
    		CITY:			NORTH BILLERICA
    		STATE:			MA
    		ZIP:			01862

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Lantheus MI Holdings, Inc.
    		DATE OF NAME CHANGE:	20110517
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>d920070dars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: d920070dars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>